Predictive performance of the 'Minto' remifentanil pharmacokinetic parameter set in morbidly obese patients ensuing from a new method for calculating lean body mass

Clinical Pharmacokinetics

Volumn 49, Issue 2, 2010, Pages 131-139

  Colla, Luca La ^a   Albertin, Andrea ^b   Colla, Giorgio La ^c   Porta, Andrea ^b   Aldegheri, Giorgio ^b   Di Candia, Domenico ^d   Gigli, Fausto ^d  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b IRCCS MULTIMEDICA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

REMIFENTANIL;

ADULT; ARTERIAL BLOOD; ARTICLE; BARIATRIC SURGERY; BODY HEIGHT; CALCULATION; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG BLOOD LEVEL; ERROR; FEMALE; FOLLOW UP; HUMAN; INTRAOPERATIVE PERIOD; LEAN BODY WEIGHT; MORBID OBESITY; OBSERVATIONAL STUDY; PERFORMANCE; PREDICTION; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS;

EID: 74249110600     PISSN: 03125963     EISSN: 11791926     Source Type: Journal    
DOI: 10.2165/11317690-000000000-00000     Document Type: Article

References (22)

1. Obesity: preventing and managing the global epidemic: report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: i-xii, 1-253
2. Adams JP, Murphy PG. Obesity inanaesthesia and intensive care. BrJAnaesth 2000; 85: 91-108
3. Agarwal N, Shibutani K, SanFilippo JA, et al. Hemodynamic and respiratory changes in surgery of the morbidly obese. Surgery 1982; 92: 226-234
4. Alexander JK. Obesity and circulation. Mod Concepts Cardiovasc Dis 1963; 32: 799-803
5. Henegar JR, Bigler SA, Henegar LK, et al. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 2001; 12: 1211-1217
6. Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil: I. Model development. Anesthesiology 1997; 86: 10-23
7. James WPT, Waterlow JC. UK Department of Health and Social Secur-ity/Medical Research Council Group on Obesity Research. Research on obesity: a report of the DHSS/MRC Group. London: Her Majesty's Stationery Office, 1976
8. La Colla L, Albertin A, La Colla G. Pharmacokinetic model-driven re-mifentanil administration in the morbidly obese: the 'critical weight' and the 'fictitious height', a possible solution to an unsolved problem? Clin Pharmacokinet 2009; 48 (6): 397-398
9. Janmahasatian S, Duffull SB, Ash S, et al. Quantification of lean bodyweight. Clin Pharmacokinet 2005; 44: 1051-1065
10. La Colla L, Albertin A, La Colla G, et al. Target controlled infusion of remifentanil: beware when using it in morbidly obese patients. First World Congress of Total Intravenous Anesthesia-TCI; 2007 Sep 27-29; Venice
11. Bossu E, Montinaro A, Lecce R, et al. LC-MS determination of remi-fentanil in maternal and neonatal plasma. J Pharm Biomed Anal 2006; 42: 367-371
12. TIVAtrainer version 5.1 [computer program; online]. Available from URL: http://www.eurosiva.org/TivaTrainer/tivatrainer-main.htm [Accessed 2009 Nov 6]
13. Rugloop version 3.28 [computer program; online]. Available from URL: http://www.demed.be/rugloop.htm [Accessed 2009 Nov 6]
14. Varvel JR, Donoho DL, Shafer SL. Measuring the predictive performance of computer-controlled infusion pumps. J Pharmacokinet Biopharm 1992; 20: 63-94
15. Miller RD, editor. Anesthesia. 6th ed. New York: Churchill Livingstone, 2006.
16. Schuttler J, Kloos S, Schwilden H, et al. Total intravenous anaesthesia with propofol and alfentanil by computer-assisted infusion. Anaesthesia 1988; 43 Suppl.: 2-7
17. Mertens MJ, Engbers FH, Burm AG, et al. Predictive performance of computer-controlled infusion of remifentanil during propofol/remifentanil anaesthesia. Br J Anaesth 2003; 90: 132-141
18. Green B, Duffull S. Caution when lean body weight is used as a size descriptor for obese subjects. Clin Pharmacol Ther 2002; 72: 743-744
19. Egan TD, Huizinga B, Gupta SK, et al. Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology 1998; 89: 562-573
20. Janmahasatian S, Duffull SB, Chagnac A, et al. Lean body mass norma-lizes the effect of obesity on renal function. Br J Clin Pharmacol 2008; 65: 964-965
21. Mertens MJ, Olofsen E, Burm AG, et al. Mixed-effects modeling of the in-fluence of alfentanil on propofol pharmacokinetics. Anesthesiology 2004; 100: 795-805
22. Vuyk J, Engbers FH, Burm AG, et al. Performance of computer-controlled infusion of propofol: an evaluation of five pharmacokinetic parameter sets. Anesth Analg 1995; 81: 1275-1282